PMDA to Focus on Proper Use of Sakigake and Conditional Approval Systems in Its 4th Midterm Plan

PMDA’s Steering Committee Meeting on Oct. 17 The Pharmaceuticals and Medical Devices Agency (PMDA) will focus on the proper use of the sakigake fast-track designation scheme and the conditional early approval system in its fourth midterm plan starting April next...read more